Boehringer Ingelheim
Shashank Deshpande has extensive experience in the pharmaceutical industry, currently serving as a Member of the Board of Managing Directors at Boehringer Ingelheim since September 2012, with roles including Country Managing Director for Japan and President of the Human Pharma Business Unit. Prior to this, Shashank Deshpande held various senior positions at sanofi-aventis from July 2002 to August 2012, focusing on portfolio strategy and market shaping in global diabetes and cardiovascular sectors. Earlier, Shashank Deshpande worked as a Senior Consultant at Capgemini, specializing in strategy and transformation. Educational credentials include an MBA in Marketing and International Management from Universität Hamburg (1993-1998).
This person is not in any offices
Boehringer Ingelheim
112 followers
At Boehringer Ingelheim they create value through innovation with one clear goal: to improve the lives of patients. They develop breakthrough therapies and innovative healthcare solutions in areas of unmet medical need for both humans and animals. As a family owned company, they focus on long-term performance. They are powered by 50.000 employees globally who nurture a diverse, collaborative and inclusive culture. Learning and development for all employees is key, because your growth is their growth.